• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

分析美国在新冠疫情前后按性别、种族和族裔划分的物质使用障碍治疗入院情况。

Analysis of Substance Use Disorder Treatment Admissions in the US by Sex and Race and Ethnicity Before and During the COVID-19 Pandemic.

机构信息

Department of Healthcare Delivery, RAND Corporation, Santa Monica, California.

Department of Healthcare Delivery, RAND Corporation, San Francisco, California.

出版信息

JAMA Netw Open. 2022 Sep 1;5(9):e2232795. doi: 10.1001/jamanetworkopen.2022.32795.

DOI:10.1001/jamanetworkopen.2022.32795
PMID:36136336
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9500559/
Abstract

This cross-sectional study examines the changes in treatment admissions for substance use disorder during the COVID-19 pandemic by sex and race and ethnicity.

摘要

这项横断面研究考察了 COVID-19 大流行期间按性别和种族和民族划分的物质使用障碍治疗入院人数的变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35e4/9500559/cd7f72acbc45/jamanetwopen-e2232795-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35e4/9500559/f24a8867da00/jamanetwopen-e2232795-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35e4/9500559/cd7f72acbc45/jamanetwopen-e2232795-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35e4/9500559/f24a8867da00/jamanetwopen-e2232795-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35e4/9500559/cd7f72acbc45/jamanetwopen-e2232795-g002.jpg

相似文献

1
Analysis of Substance Use Disorder Treatment Admissions in the US by Sex and Race and Ethnicity Before and During the COVID-19 Pandemic.分析美国在新冠疫情前后按性别、种族和族裔划分的物质使用障碍治疗入院情况。
JAMA Netw Open. 2022 Sep 1;5(9):e2232795. doi: 10.1001/jamanetworkopen.2022.32795.
2
Coronavirus Disease 2019 and the Impact on Substance Use Disorder Treatments.新型冠状病毒肺炎 2019 年与物质使用障碍治疗的影响。
Psychiatr Clin North Am. 2022 Mar;45(1):95-107. doi: 10.1016/j.psc.2021.11.006. Epub 2021 Nov 12.
3
Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 omicron infection and related hospital admission among people with substance use disorder in Hong Kong: a matched case-control study.BNT162b2 和科兴疫苗对香港有药物滥用史人群感染奥密克戎和相关住院的有效性：一项匹配病例对照研究。
Lancet Psychiatry. 2023 Jun;10(6):403-413. doi: 10.1016/S2215-0366(23)00111-6. Epub 2023 May 1.
4
Association of Social and Behavioral Risk Factors With Mortality Among US Veterans With COVID-19.社会行为风险因素与美国 COVID-19 退伍军人死亡率的关联。
JAMA Netw Open. 2021 Jun 1;4(6):e2113031. doi: 10.1001/jamanetworkopen.2021.13031.
5
Changes in Admissions to Specialty Addiction Treatment Facilities in California During the COVID-19 Pandemic.加利福尼亚州在 COVID-19 大流行期间专科成瘾治疗机构入院人数的变化。
JAMA Netw Open. 2021 Jul 1;4(7):e2117029. doi: 10.1001/jamanetworkopen.2021.17029.
6
A Descriptive Comparison of Substance Use Services in Recovery and Isolation Sites for People Experiencing Homelessness During the COVID-19 Pandemic, Boston and Toronto.新冠疫情期间波士顿和多伦多为无家可归者设立的康复与隔离场所内物质使用服务的描述性比较
Public Health Rep. 2021 Sep-Oct;136(5):532-537. doi: 10.1177/00333549211032974. Epub 2021 Jul 16.
7
Converging Crises: Caring for Hospitalized Adults With Substance Use Disorder in the Time of COVID-19.多重危机：在新冠疫情期间照顾患有物质使用障碍的住院成年人
J Hosp Med. 2020 Oct;15(10):628-630. doi: 10.12788/jhm.3485.
8
COVID-19 and persons with substance use disorders: Inequities and mitigation strategies.新型冠状病毒肺炎与物质使用障碍患者：不公平现象与缓解策略。
Subst Abus. 2020;41(3):286-291. doi: 10.1080/08897077.2020.1784363.
9
Associations between trauma and substance use among healthcare workers and public safety personnel during the SARS-CoV-2 (COVID-19) pandemic: the mediating roles of dissociation and emotion dysregulation.在 SARS-CoV-2（COVID-19）大流行期间，医护人员和公共安全人员的创伤与物质使用之间的关联：分离和情绪调节障碍的中介作用。
Eur J Psychotraumatol. 2023;14(1):2180706. doi: 10.1080/20008066.2023.2180706.
10
Associations Between Substance Use Problems and Stress During COVID-19.新冠疫情期间物质使用问题与压力的关联
J Stud Alcohol Drugs. 2021 Nov;82(6):776-781. doi: 10.15288/jsad.2021.82.776.

引用本文的文献

1
Recognising the heterogeneity of Indigenous Peoples during the COVID-19 pandemic: a scoping review across Canada, Australia, New Zealand and the USA.认识新冠疫情期间原住民的异质性：对加拿大、澳大利亚、新西兰和美国的一项范围综述
BMJ Public Health. 2024 Dec 30;2(2):e001341. doi: 10.1136/bmjph-2024-001341. eCollection 2024 Dec.
2
Global, regional, and national trends in drug use disorder mortality rates across 73 countries from 1990 to 2021, with projections up to 2040: a global time-series analysis and modelling study.1990年至2021年73个国家药物使用障碍死亡率的全球、区域和国家趋势以及到2040年的预测：一项全球时间序列分析与建模研究
EClinicalMedicine. 2024 Dec 17;79:102985. doi: 10.1016/j.eclinm.2024.102985. eCollection 2025 Jan.
3

本文引用的文献

1
Evaluation of Increases in Drug Overdose Mortality Rates in the US by Race and Ethnicity Before and During the COVID-19 Pandemic.评估新冠疫情前后美国按种族和族裔划分的药物过量死亡率上升情况。
JAMA Psychiatry. 2022 Apr 1;79(4):379-381. doi: 10.1001/jamapsychiatry.2022.0004.
2
Changes in Admissions to Specialty Addiction Treatment Facilities in California During the COVID-19 Pandemic.加利福尼亚州在 COVID-19 大流行期间专科成瘾治疗机构入院人数的变化。
JAMA Netw Open. 2021 Jul 1;4(7):e2117029. doi: 10.1001/jamanetworkopen.2021.17029.
3
Trends in visits to substance use disorder treatment facilities in 2020.
Estimated effectiveness and cost-effectiveness of opioid use disorder treatment under proposed U.S. regulatory relaxations: A model-based analysis.拟议的美国监管放宽政策下阿片类药物使用障碍治疗的估计效果和成本效益：基于模型的分析。
Drug Alcohol Depend. 2024 Mar 1;256:111112. doi: 10.1016/j.drugalcdep.2024.111112. Epub 2024 Feb 1.
4
Evidence of telescoping in females across two decades of US treatment admissions for injection drug use: 2000-2020.2000年至2020年美国因注射吸毒接受治疗的女性中出现套叠现象的证据。
Drug Alcohol Depend Rep. 2023 Nov 10;9:100204. doi: 10.1016/j.dadr.2023.100204. eCollection 2023 Dec.
5
Educational Attainment and US Drug Overdose Deaths.受教育程度与美国药物过量死亡人数
JAMA Health Forum. 2023 Oct 6;4(10):e233274. doi: 10.1001/jamahealthforum.2023.3274.
6
Overall and Telehealth Addiction Treatment Utilization by Age, Race, Ethnicity, and Socioeconomic Status in California After COVID-19 Policy Changes.加利福尼亚州在 COVID-19 政策变化后，按年龄、种族、族裔和社会经济地位划分的总体和远程医疗成瘾治疗利用率。
JAMA Health Forum. 2023 May 5;4(5):e231018. doi: 10.1001/jamahealthforum.2023.1018.
7
Circadian rhythmicity in schizophrenia male patients with and without substance use disorder comorbidity.精神分裂症男性患者伴或不伴物质使用障碍共病的昼夜节律性。
Eur Arch Psychiatry Clin Neurosci. 2024 Mar;274(2):279-290. doi: 10.1007/s00406-023-01560-7. Epub 2023 Mar 6.
8
Perceptions of COVID-19 risk during the pandemic: perspectives from people seeking medication for opioid use disorder.大流行期间对 COVID-19 风险的认知：阿片类药物使用障碍患者寻求药物治疗的观点。
Ann Med. 2023 Dec;55(1):480-489. doi: 10.1080/07853890.2023.2169342.
2020年物质使用障碍治疗机构就诊趋势。
J Subst Abuse Treat. 2021 Aug;127:108462. doi: 10.1016/j.jsat.2021.108462. Epub 2021 May 11.
4
Common themes in early state policy responses to substance use disorder treatment during COVID-19.在 COVID-19 期间，早期国家政策对物质使用障碍治疗的常见主题。
Am J Drug Alcohol Abuse. 2021 Jul 4;47(4):486-496. doi: 10.1080/00952990.2021.1903023. Epub 2021 Apr 28.
5
Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic - United States, June 24-30, 2020.《2020 年 6 月 24 日至 30 日美国在新冠疫情期间的心理健康、物质使用和自杀意念状况》
MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69(32):1049-1057. doi: 10.15585/mmwr.mm6932a1.